Skip to main content

Peer Review reports

From: N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

Original Submission
19 Jul 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 Sep 2016 Editorially accepted
15 Sep 2016 Article published 10.1186/s12888-016-1030-3

You can find further information about peer review here.

Back to article page